| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |